Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Trifluoperazine 1mg/5ml oral solution sugar free
0402010X0AAAFAF
|
Trifluoperazine | Trifluoperazine | Central Nervous System | 57 |
|
Abilify 30mg tablets
0402010ADBBACAC
|
Abilify | Aripiprazole | Central Nervous System | 56 |
|
Apomorphine 100mg/20ml solution for infusion vials
0409010ACAAABAB
|
Apomorph hydrochloride hemihydrate (Parkinsonism) | Apomorphine hydrochloride hemihydrate | Central Nervous System | 56 |
|
Carlosafine 52.5micrograms/hour transdermal patches
0407020B0BTABAF
|
Carlosafine | Buprenorphine | Central Nervous System | 56 |
|
Nicotine 450micrograms/dose inhaler CFC free
0410020B0AACDCD
|
Nicotine | Nicotine | Central Nervous System | 56 |
|
Paracetamol 500mg / Ibuprofen 200mg tablets
0407010ADAAAAAA
|
Paracetamol/ibuprofen | Paracetamol and ibuprofen | Central Nervous System | 56 |
|
Reletrans 40micrograms/hour transdermal patches
0407020B0BKAGAN
|
Reletrans | Buprenorphine | Central Nervous System | 56 |
|
Venlafaxine 75mg/5ml oral suspension
0403040W0AAARAR
|
Venlafaxine | Venlafaxine | Central Nervous System | 56 |
|
Victanyl 12micrograms/hour transdermal patches
0407020A0BMAEAU
|
Victanyl | Fentanyl | Central Nervous System | 56 |
|
Buprenorphine 128mg/0.36ml prolonged-release inj pfs
0410030A0AAAUAU
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 55 |
|
Edronax 4mg tablets
0403040U0BBAAAA
|
Edronax | Reboxetine | Central Nervous System | 55 |
|
Naltrexone 5mg/5ml oral solution
0410030E0AAAVAV
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | 55 |
|
Phenelzine 15mg capsules
0403020M0AAABAB
|
Phenelzine sulfate | Phenelzine sulfate | Central Nervous System | 55 |
|
Ritalin XL 40mg capsules
0404000M0BBAGAW
|
Ritalin | Methylphenidate hydrochloride | Central Nervous System | 55 |
|
Betahistine 8mg/5ml oral suspension
0406000B0AAAGAG
|
Betahistine hydrochloride | Betahistine hydrochloride | Central Nervous System | 54 |
|
Lamictal 2mg dispersible tablets
0408010H0BBAKBJ
|
Lamictal | Lamotrigine | Central Nervous System | 54 |
|
Metharose 1mg/ml oral solution sugar free
0410030C0BEAAAF
|
Metharose | Methadone hydrochloride | Central Nervous System | 54 |
|
Oxylan 15mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFAKAS
|
Oxylan | Oxycodone hydrochloride | Central Nervous System | 54 |
|
Zamadol 24hr 150mg modified-release tablets
040702040BDAHAD
|
Zamadol | Tramadol hydrochloride | Central Nervous System | 54 |
|
Atrolak XL 300mg tablets
0402010ABBGACAX
|
Atrolak XL | Quetiapine | Central Nervous System | 53 |
|
Levetiracetam 1g gran for soln sachets sugar free
0408010A0AAAUAU
|
Levetiracetam | Levetiracetam | Central Nervous System | 53 |
|
Quetiapine 12.5mg/5ml oral solution
0402010ABAAAIAI
|
Quetiapine | Quetiapine | Central Nervous System | 53 |
|
Stemetil 5mg/5ml syrup
0406000U0BBAAAA
|
Stemetil (Injection/Sachet/Syrup) | Prochlorperazine mesilate | Central Nervous System | 53 |
|
Tramquel SR 100mg capsules
040702040BJABAH
|
Tramquel | Tramadol hydrochloride | Central Nervous System | 53 |
|
Vertigon 25mg tablets
0406000V0BCAAAA
|
Vertigon | Promethazine teoclate | Central Nervous System | 53 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.